IL1B and inflammation: Furthermore, they suppress NLPR3 inflammasome activation to reduce IL-1β and TGF-β/Smads signaling via CD36-mediated TLR4/6-IRAK4/1 signaling in animal and cell models, exhibiting the alleviation of fructose-induced cardiac inflammation and fibrosis.